Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Option Award |
2025-03-04 5:11 pm |
N/A 2035-02-28 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
530,930 | $0 | 530,930 (Direct) |
View |
| 2025-02-21 Tax Withholding |
2025-02-25 4:09 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
19,904 | $5.54 | 2,601,958 (Direct) |
View |
| 2025-02-14 Tax Withholding |
2025-02-19 4:52 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
37,731 | $5.42 | 2,621,862 (Direct) |
View |
| 2024-03-01 Option Award |
2024-11-27 6:04 pm |
N/A 2034-02-28 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
315,316 | $0 | 315,316 (Direct) |
View |
| 2024-11-21 Tax Withholding |
2024-11-25 4:29 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
19,910 | $6.44 | 2,659,593 (Direct) |
View |
| 2024-11-14 Tax Withholding |
2024-11-18 4:26 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
60,256 | $7.92 | 2,679,503 (Direct) |
View |
| 2024-08-21 Tax Withholding |
2024-08-23 4:11 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO |
79,616 | $9.19 | 2,739,759 (Direct) |
View |
| 2024-08-14 Tax Withholding |
2024-08-16 4:47 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
59,765 | $7.02 | 2,819,375 (Direct) |
View |
| 2024-05-14 Tax Withholding |
2024-05-16 6:54 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
54,918 | $8.36 | 2,879,630 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:06 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
41,861 | $3.4 | 2,935,038 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
239,023 | $5.08 | 2,977,478 (Direct) |
View |
| 2023-08-21 Option Award |
2023-08-23 4:19 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
493,994 | $0 | 3,218,401 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 8:40 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
33,605 | $3.88 | 2,877,492 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 8:40 pm |
N/A 2032-03-22 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
33,605 | $0 | 2,877,492 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:05 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
1,785,336 | $0 | 2,951,191 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
0 | $0 | 1,601,465 (Direct) |
View |